NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
DAWN Day One Biopharmaceuticals
- 9.870
- 0.0000.00%
Trading Feb 27 11:49 ET
1.00BMarket Cap-9.68P/E (TTM)
10.060High9.480Low633.20KVolume9.930Open9.870Pre Close6.21MTurnover0.88%Turnover RatioLossP/E (Static)101.35MShares18.07052wk High1.99P/B710.65MFloat Cap9.48052wk Low--Dividend TTM72.00MShs Float28.699Historical High--Div YieldTTM5.88%Amplitude5.440Historical Low9.814Avg Price1Lot Size
Day One Biopharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 45.14%531.72M | 45.14%531.72M | 37.69%558.38M | -18.29%361.87M | -0.07%317.94M | 7.03%366.35M | 7.03%366.35M | 8.33%405.54M | 12.16%442.88M | 21.10%318.18M |
| -Cash and cash equivalents | -45.85%124.97M | -45.85%124.97M | 75.29%422.77M | 26.64%239.62M | 448.82%270.39M | 170.68%230.78M | 170.68%230.78M | 99.55%241.18M | -51.34%189.21M | -81.25%49.27M |
| -Short-term investments | 200.05%406.75M | 200.05%406.75M | -17.49%135.62M | -51.81%122.25M | -82.32%47.55M | -47.25%135.56M | -47.25%135.56M | -35.16%164.36M | 4,137.03%253.67M | --268.91M |
| Receivables | --13.88M | --13.88M | --8.7M | --9.14M | ---- | --0 | --0 | ---- | ---- | ---- |
| -Accounts receivable | --13.88M | --13.88M | --8.7M | --9.14M | ---- | --0 | --0 | ---- | ---- | ---- |
| Inventory | --3.32M | --3.32M | --2.74M | --151K | ---- | --0 | --0 | ---- | ---- | ---- |
| Prepaid assets | 37.58%9.05M | 37.58%9.05M | 39.96%7.74M | 55.84%9.54M | 44.76%4.96M | 42.97%6.58M | 42.97%6.58M | 5.78%5.53M | -9.99%6.12M | -19.16%3.43M |
| Other current assets | 85.67%4.37M | 85.67%4.37M | 54.88%3.45M | 215.75%2.47M | 300.13%3.13M | 133.80%2.35M | 133.80%2.35M | 135.20%2.23M | -6.91%781K | 96.48%782K |
| Total current assets | 49.85%562.33M | 49.85%562.33M | 40.58%581M | -14.81%383.16M | 1.13%326.03M | 7.88%375.27M | 7.88%375.27M | 8.61%413.29M | 11.75%449.78M | 20.58%322.39M |
| Non current assets | ||||||||||
| Net PPE | 740.54%4.71M | 740.54%4.71M | 430.99%3.48M | -49.51%360K | -35.47%444K | -22.11%560K | -22.11%560K | -27.14%655K | -32.74%713K | 179.67%688K |
| -Gross PPE | 740.54%4.71M | 740.54%4.71M | 407.74%3.48M | -50.75%360K | -36.57%444K | -22.11%560K | -22.11%560K | -30.24%685K | -33.97%731K | 143.90%700K |
| -Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 63.86%-30K | 61.70%-18K | 70.73%-12K |
| Goodwill and other intangible assets | --15.63M | --15.63M | --16.22M | --16.8M | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non current assets | -43.46%121K | -43.46%121K | -49.79%117K | -54.83%117K | -65.71%167K | -54.37%214K | -54.37%214K | -48.11%233K | -46.49%259K | 195.15%487K |
| Total non current assets | 2,543.15%20.46M | 2,543.15%20.46M | 2,130.97%19.81M | 1,677.67%17.28M | -48.00%611K | -34.85%774K | -34.85%774K | -34.12%888K | -37.05%972K | 185.89%1.18M |
| Total assets | 54.98%582.79M | 54.98%582.79M | 45.06%600.81M | -11.16%400.44M | 0.95%326.65M | 7.73%376.05M | 7.73%376.05M | 8.46%414.18M | 11.56%450.76M | 20.83%323.56M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 26.63%3.26M | 26.63%3.26M | -11.03%3.02M | 41.16%6.44M | 2.64%4.78M | 890.77%2.58M | 890.77%2.58M | -14.65%3.39M | 939.86%4.57M | 564.34%4.66M |
| -accounts payable | 26.63%3.26M | 26.63%3.26M | -11.03%3.02M | 41.16%6.44M | 2.64%4.78M | 890.77%2.58M | 890.77%2.58M | -14.65%3.39M | 939.86%4.57M | 564.34%4.66M |
| Current accrued expenses | 121.56%56.46M | 121.56%56.46M | 51.67%30.69M | 334.18%83.94M | 38.39%23.89M | 61.58%25.48M | 61.58%25.48M | 51.22%20.24M | 64.23%19.33M | 149.52%17.26M |
| Current debt and capital lease obligation | -97.55%10K | -97.55%10K | -82.38%77K | -55.61%190K | -28.06%300K | 0.74%408K | 0.74%408K | -5.41%437K | 0.23%428K | 143.86%417K |
| -Current capital lease obligation | -97.55%10K | -97.55%10K | -82.38%77K | -55.61%190K | -28.06%300K | 0.74%408K | 0.74%408K | -5.41%437K | 0.23%428K | 143.86%417K |
| Current deferred liabilities | --1.55M | --1.55M | --1.46M | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other current liabilities | 1,068.49%12.16M | 1,068.49%12.16M | 999.02%4.5M | 1,583.87%3.13M | 69.71%874K | 481.56%1.04M | 481.56%1.04M | -9.71%409K | 15.53%186K | 33.07%515K |
| Current liabilities | 148.92%73.45M | 148.92%73.45M | 62.39%39.75M | 282.29%93.71M | 30.60%29.84M | 77.60%29.51M | 77.60%29.51M | 33.96%24.48M | 91.51%24.51M | 179.45%22.85M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --2.59M | --2.59M | 3,196.10%2.54M | ---- | ---- | --0 | --0 | -85.02%77K | -69.21%190K | --300K |
| -Long term capital lease obligation | --2.59M | --2.59M | 3,196.10%2.54M | ---- | ---- | --0 | --0 | -85.02%77K | -69.21%190K | --300K |
| Non current deferred liabilities | --3.23M | --3.23M | --3.06M | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non current liabilities | --761K | --761K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | --6.59M | --6.59M | 7,171.43%5.6M | --0 | --0 | --0 | --0 | -85.02%77K | -69.21%190K | --300K |
| Total liabilities | 171.24%80.04M | 171.24%80.04M | 84.69%45.34M | 279.35%93.71M | 28.91%29.84M | 73.34%29.51M | 73.34%29.51M | 30.70%24.55M | 84.12%24.7M | 183.12%23.15M |
| Shareholders'equity | ||||||||||
| Share capital | 11.11%10K | 11.11%10K | 11.11%10K | 0.00%9K | 28.57%9K | 28.57%9K | 28.57%9K | 28.57%9K | 28.57%9K | 16.67%7K |
| -common stock | 11.11%10K | 11.11%10K | 11.11%10K | 0.00%9K | 28.57%9K | 28.57%9K | 28.57%9K | 28.57%9K | 28.57%9K | 16.67%7K |
| Retained earnings | -20.82%-554.08M | -20.82%-554.08M | -20.86%-488.37M | -46.79%-525.4M | -66.95%-521M | -70.06%-458.59M | -70.06%-458.59M | -76.02%-404.07M | -86.65%-357.92M | -101.03%-312.06M |
| Paid-in capital | 31.25%1.06B | 31.25%1.06B | 31.51%1.04B | 6.14%832.15M | 33.54%817.8M | 33.79%805.11M | 33.79%805.11M | 33.84%793.7M | 34.61%783.98M | 47.63%612.4M |
| Gains losses not affecting retained earnings | 833.33%84K | 833.33%84K | 14.29%-6K | -144.44%-22K | -107.46%-5K | 112.68%9K | 112.68%9K | 98.21%-7K | -200.00%-9K | --67K |
| Total stockholders'equity | 45.08%502.75M | 45.08%502.75M | 42.56%555.46M | -28.01%306.73M | -1.20%296.81M | 4.37%346.54M | 4.37%346.54M | 7.31%389.63M | 9.07%426.05M | 15.72%300.42M |
| Total equity | 45.08%502.75M | 45.08%502.75M | 42.56%555.46M | -28.01%306.73M | -1.20%296.81M | 4.37%346.54M | 4.37%346.54M | 7.31%389.63M | 9.07%426.05M | 15.72%300.42M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |